These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 26489733)

  • 1. Engineering immunity: Modulating dendritic cell subsets and lymph node response to direct immune-polarization and vaccine efficacy.
    Leleux J; Atalis A; Roy K
    J Control Release; 2015 Dec; 219():610-621. PubMed ID: 26489733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell-based vaccine research against cancer.
    Mody N; Dubey S; Sharma R; Agrawal U; Vyas SP
    Expert Rev Clin Immunol; 2015 Feb; 11(2):213-32. PubMed ID: 25467734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migration of dendritic cells to the lymph nodes and its enhancement to drive anti-tumor responses.
    Seyfizadeh N; Muthuswamy R; Mitchell DA; Nierkens S; Seyfizadeh N
    Crit Rev Oncol Hematol; 2016 Nov; 107():100-110. PubMed ID: 27823637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Strategies for Lymph Node Targeted Immune Activation.
    Chen Y; De Koker S; De Geest BG
    Acc Chem Res; 2020 Oct; 53(10):2055-2067. PubMed ID: 32910636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the Functional Properties of Neonatal Dendritic Cells: A Doorway to Enhance Vaccine Effectiveness?
    Papaioannou NE; Pasztoi M; Schraml BU
    Front Immunol; 2018; 9():3123. PubMed ID: 30687326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD11b+ DCs rediscovered: implications for vaccination.
    Ginhoux F; Schlitzer A
    Expert Rev Vaccines; 2014 Apr; 13(4):445-7. PubMed ID: 24564769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
    Klippstein R; Pozo D
    Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering vaccines and niches for immune modulation.
    Purwada A; Roy K; Singh A
    Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting vaccines to dendritic cells.
    Foged C; Sundblad A; Hovgaard L
    Pharm Res; 2002 Mar; 19(3):229-38. PubMed ID: 11934227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction.
    Okada N; Mori N; Koretomo R; Okada Y; Nakayama T; Yoshie O; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T; Fujita T; Yamamoto A
    Gene Ther; 2005 Jan; 12(2):129-39. PubMed ID: 15483669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance.
    Andorko JI; Hess KL; Jewell CM
    AAPS J; 2015 Mar; 17(2):323-38. PubMed ID: 25533221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine.
    Foley R; Tozer R; Wan Y
    Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of macrophage and dendritic cell function by pathogens and through immunomodulation in the avian mucosa.
    de Geus ED; Vervelde L
    Dev Comp Immunol; 2013 Nov; 41(3):341-51. PubMed ID: 23542704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines.
    Tacken PJ; Figdor CG
    Semin Immunol; 2011 Feb; 23(1):12-20. PubMed ID: 21269839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting dendritic cells with biomaterials: developing the next generation of vaccines.
    Reddy ST; Swartz MA; Hubbell JA
    Trends Immunol; 2006 Dec; 27(12):573-9. PubMed ID: 17049307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection.
    Kaminsky LW; Sei JJ; Parekh NJ; Davies ML; Reider IE; Krouse TE; Norbury CC
    J Virol; 2015 Oct; 89(19):9974-85. PubMed ID: 26202250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dendritic cells of mucosa and skin: "recruited for vaccination"].
    Le Borgne M; Dubois B; Kaiserlian D
    Med Sci (Paris); 2007 Oct; 23(10):819-25. PubMed ID: 17937889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Conventional Dendritic Cells to Fine-Tune Antibody Responses.
    Tesfaye DY; Gudjonsson A; Bogen B; Fossum E
    Front Immunol; 2019; 10():1529. PubMed ID: 31333661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance.
    Nirschl CJ; Anandasabapathy N
    Hum Vaccin Immunother; 2016; 12(1):104-16. PubMed ID: 26836327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.